Call Options

27 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $1.11 Million - $1.36 Million
6,800 Added 26.56%
32,400 $6.4 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $2.69 Million - $3.15 Million
-17,400 Reduced 40.47%
25,600 $4.39 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $1.1 Million - $1.26 Million
-6,900 Reduced 13.83%
43,000 $7.83 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $26,718 - $30,930
200 Added 0.4%
49,900 $7.44 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $4.68 Million - $5.82 Million
-35,300 Reduced 41.53%
49,700 $6.7 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $4.84 Million - $5.58 Million
-33,500 Reduced 28.27%
85,000 $13.5 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $9.06 Million - $10.9 Million
65,500 Added 123.58%
118,500 $19.2 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $3.44 Million - $3.94 Million
-25,600 Reduced 32.57%
53,000 $7.25 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $1.43 Million - $1.82 Million
10,400 Added 15.25%
78,600 $12.1 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $5.02 Million - $6.22 Million
38,000 Added 125.83%
68,200 $11.2 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $429,720 - $543,720
-4,000 Reduced 11.7%
30,200 $4.09 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $3.54 Million - $4.02 Million
33,300 Added 3700.0%
34,200 $3.72 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $4.2 Million - $4.68 Million
-39,900 Reduced 97.79%
900 $101,000
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $1.45 Million - $1.6 Million
-14,200 Reduced 25.82%
40,800 $4.42 Million
Q4 2020

Feb 25, 2021

SELL
$80.49 - $108.67 $1.75 Million - $2.36 Million
-21,700 Reduced 28.29%
55,000 $5.89 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $6.64 Million - $7.79 Million
-77,300 Reduced 50.19%
76,700 $6.75 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $11.5 Million - $17.4 Million
-178,400 Reduced 53.67%
154,000 $11.8 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $2.98 Million - $3.73 Million
41,300 Added 14.19%
332,400 $29.2 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $7.09 Million - $8.53 Million
112,600 Added 63.08%
291,100 $22 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $7.72 Million - $9.87 Million
-117,500 Reduced 39.7%
178,500 $13 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $9.46 Million - $11.1 Million
122,600 Added 70.7%
296,000 $23.9 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $7.86 Million - $9.7 Million
101,000 Added 139.5%
173,400 $16 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $2.38 Million - $2.65 Million
26,800 Added 58.77%
72,400 $6.85 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $13 Million - $15.4 Million
-145,000 Reduced 76.08%
45,600 $4.23 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $4.3 Million - $5.75 Million
-46,700 Reduced 19.68%
190,600 $18 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $1.39 Million - $1.78 Million
19,900 Added 9.15%
237,300 $21.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
217,400
217,400 $15.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.